![]() |
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
This immunotherapy combination shrinks rare, neuroendocrine: Study TheHealthSiteAccording to a new study, after using a combination of ipilimumab (6 weeks) and nivolumab (2 weeks) the results showed that 42 per cent of patients with the ...
أكثر... ??????? ??????: This immunotherapy combination shrinks rare, neuroendocrine: Study - TheHealthSite || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|